Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Kidney & Blood Pressure Research|July 11, 2019
A Potential Mechanism of Cardio-Renal Protection with Sodium-Glucose Cotransporter 2 Inhibitors: Amelioration of Renal CongestionSatoru Kuriyama
Clinical and Experimental Nephrology|January 24, 2020
Correction to: Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemiaSatoru Kuriyama
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|November 22, 2007
Peritoneal dialysis in patients with diabetes: are the benefits greater than the disadvantages?Satoru Kuriyama
Clinical and Experimental Nephrology|November 28, 2018
Protection of the kidney with sodium-glucose cotransporter 2 inhibitors: potential mechanisms raised by the large-scaled randomized control trialsSatoru Kuriyama
Clinical and Experimental Nephrology|November 23, 2019
Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemiaSatoru Kuriyama
Nihon Rinsho. Japanese Journal of Clinical Medicine|October 26, 2002
[A clinical evaluation on the combination therapy with ACE-I and ARB, and with ARB and CCB in patients with progressive chronic renal diseases]Satoru Kuriyama
Clinical and Experimental Nephrology|June 23, 2006
Pseudoaldosteronism due to the concurrent use of two herbal medicines containing glycyrrhizin: interaction of glycyrrhizin with angiotensin-converting enzyme inhibitorRinako Iida, Yasushi Otsuka, Kei Matsumoto, et al.
Clinical and Experimental Nephrology|March 27, 2007
Morning blood pressure at home predicts erythropoietin-induced hypertension in patients with chronic renal diseasesSatoru Kuriyama, Yasushi Otsuka, Rinako Iida, et al.
Nihon Jinzo Gakkai Shi|August 19, 2007
[Current management of renal anemia in patients with chronic kidney disease at the predialysis stage]Satoru Kuriyama, Yasushi Otsuka, Daijiro Uetake, et al.
Nihon Jinzo Gakkai Shi|December 23, 2006
[Regression of cardiac hypertrophy using angiotensin II receptor blocker in patients with chronic kidney diseases]Satoru Kuriyama, Yasushi Otsuka, Daijiro Uetake, et al.
Pageof 4